Conditions: Bacterial Conjunctivitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 518
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the safety of Besivance (besifloxacin ophthalmic suspension, 0.6%) compared to vehicle.

Detailed description:

Arms:
arm 1: besifloxacin ophthalmic suspension 0.6% arm 2: Vehicle of Besivance

Interventions: intervention 1: Besivance intervention 2: Vehicle
Intervention descriptions: intervention 1: Ocular administration to affected eye for 7 days intervention 2: Vehicle of Besivance administered to affected eye for 7 days

Protocol document: